RT Journal Article
SR Electronic
T1 Outcome measures in psoriatic arthritis.
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 1159
OP 1166
VO 34
IS 5
A1 Gladman, Dafna D
A1 Mease, Philip J
A1 Healy, Paul
A1 Helliwell, Philip S
A1 Fitzgerald, Oliver
A1 Cauli, Alberto
A1 Lubrano, Ennio
A1 Krueger, Gerald G
A1 van der Heijde, Désirée
A1 Veale, Douglas J
A1 Kavanaugh, Arthur
A1 Nash, Peter
A1 Ritchlin, Christopher
A1 Taylor, William
A1 Strand, Vibeke
YR 2007
UL http://www.jrheum.org/content/34/5/1159.abstract
AB Psoriatic arthritis (PsA), an inflammatory arthritis associated with psoriasis usually seronegative for rheumatoid factor, has emerged as a more common and severe disease than previously appreciated. The disease is multifaceted. Thus the assessment of PsA requires attention to peripheral joint involvement, axial disease, dactylitis, and enthesitis, as well as the skin manifestations. In addition, the assessment of patient reported features such as patient assessment of disease activity, pain, fatigue, quality of life, and the new concept of participation are important. The assessment of damage and the assessment of tissue histology are also important outcome measures. This article summarizes these features of PsA as well as current knowledge on the instruments available for the assessment of these domains.